59 results
8-K
EX-99.1
ELUT
Elutia Inc - Ordinary Shares
9 May 24
Results of Operations and Financial Condition
5:26pm
sales were $6.7 million, an increase of 5%.
Net sales of SimpliDerm were $3.6 million, compared to $2.3 million, an increase of 55%, as customer
8-K
EX-10.1
ELUT
Elutia Inc - Ordinary Shares
1 Apr 24
Entry into a Material Definitive Agreement
5:00pm
for (a) quantity, trade, cash or other discounts, allowances, credits or rebates (including customer rebates) actually allowed or taken, (b) amounts … ), (vi) distribution, marketing or supply agreements to which any Loan Party is a party, (vii) customer agreements to which any Loan Party is a party
8-K
EX-99.1
u8novi 9ew0
20 Nov 23
Other Events
4:02pm
8-K
EX-10.2
ejd87bcn5sn0 02
15 Nov 23
Unaudited Pro Forma Condensed Consolidated Financial Statements
5:26pm
8-K
m1wbvcxdx306a7 agx
15 Nov 23
Unaudited Pro Forma Condensed Consolidated Financial Statements
5:26pm
8-K
EX-99.1
usrd5hcil3ih
13 Nov 23
Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results
4:28pm
8-K
gv7i4ucjaw2cyd
9 Nov 23
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
9:19am
8-K
EX-99.1
uuv dmevps
9 Nov 23
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
9:19am
8-K
EX-10.1
t0hmdqi 52i4kr7
21 Sep 23
Elutia Announces Private Placement for Proceeds Up to $26 Million
4:05pm
8-K
EX-99.1
pj1l87vl7x2nw5kst4py
21 Sep 23
Elutia Announces Private Placement for Proceeds Up to $26 Million
4:05pm
8-K
EX-10.1
xdatn
19 Sep 23
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
8:30am
8-K
c076tyy9oeilob3gx
19 Sep 23
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
8:30am
8-K
EX-99.1
lfmr2n els02e39c3
19 Sep 23
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
8:30am
8-K
EX-99.1
y7l2jx789e7xpmuv gk2
7 Sep 23
Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
8:30am